Campus Create Co, Ltd will hold the second Global Innovation Online Business Matching Seminar on March 23, 2022, titled “USA ‘s Cutting-Edge Life Sciences Research for Happier, Healthier, Longer Lives！”, to introduce the new technologies and products in healthcare industry from USA`s universities and startup companies.
We are waiting for your participation.
【Date・Time】
March 23, 2022(Wed.) 9:00～11:00(Japan Time)
Online seminar via ZOOM
Free to register
↓↓
https://us02web.zoom.us/webinar/register/WN_qa_zMi8gSQWQd1U0lkDyMg
【Program】
9:00～9:10 Opening Remarks from Organizer Campus Create Co., Ltd
9:10～9:15 Greeting from Co-Organizers
KOSEI LLC
UNM Rainforest Innovations
9:15～9:45 Oral Gelling Liquid Formulations
Prof. Jason McConville, University of New Mexico
9:45～10:15 A New Groundbreaking Disinfectant –A Covid-19 Killer —
CEO and Founder, Dr. David Whitten, Biosafe Defenses LLC
10:15～10:45 Pioneering Respiratory Patient Care
Executive Chairman, Mr. Paul Atkins, NobHill Therapeutic Inc
10:45～11:00 Closing Remarks
【Speech Introduction 】
- Speech
Speech Title: Oral Gelling Liquid Formulations
Speaker: Prof. Jason McConville, University of New Mexico
Abstract:
An active gelling aid (e.g. sodium fluoride) enables the spontaneous formation of a gel from a low viscosity polymer liquid at 37 °C The liquid, which can be applied to the oral cavity by spraying, covers the tooth surface without gaps and quickly gels at body temperature. It can enable the release of active ingredients effective for tooth remineralization for a long time. In this presentation, this oral Gelling Liquid Formulations will be introduced.
- Speech
Speech Title: A New Groundbreaking Disinfectant –A Covid-19 Killer —
Speaker: CEO and Founder, Dr. David Whitten, Biosafe Defenses LLC
Abstract:
Biosafe Defenses LLC Announces a New Groundbreaking Disinfectant after 10 Years of Research. This new disinfectant can continue to disinfect surfaces for up to 24 hours nonstop after only one application, which is 48 times longer than any other antimicrobial. Now, they are applying to USA’s EPA for approval of an entirely new class of biocide, which when approved, will be the first new disinfectant approved in over 30 years.
- Speech
Speech Title: Pioneering Respiratory Patient Care
Speaker: Executive Chairman, Mr. Paul Atkins, NobHill Therapeutic Inc
Abstract:
Introduction the first of its kind dry powder nebulizer (DryNeb) inhalation drug delivery platform that can effectively deliver drugs into the patient’s lungs at high concentrations independent of the patient’s lung capacity. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.